Pham Quang X

Chairman and CEO at CVKD

Sold, on record
$701k
Dollars the filings state
Form 4 sales
16
Latest Jun 29, 2026
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • CVKDCadrenal Therapeutics, Inc.Chairman and CEO

Sales by reason

6
Routine
0
Plan not stated
0
No plan
4
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale CVKDRoutine
    Jun 2, 2026 2026

    Sold 652 shares at $4.72 ($3k)

    Pham Quang X, CEO and Chairman

    10b5-1 planSold 0.4% of holdings ($859k position)181,509 shares left0.2x usual sizeFiling

  2. 2 Form 4 sale CVKDUnusual
    Jun 5, 2026 +3 days

    Sold 8,285 shares at $4.37 ($36k)

    Pham Quang X, CEO and Chairman

    10b5-1 planSold 4.6% of holdings ($793k position)173,224 shares left3.4x usual sizeFiling

  3. 3 Form 4 sale CVKDUnusual
    Jun 10, 2026 +5 days

    Sold 22,385 shares at $4.17 ($93k)

    Pham Quang X, Chairman, CEO and Interim CFO

    10b5-1 planSold 12.9% of holdings ($722k position)150,839 shares left7.4x usual sizeFiling

  4. 4 Form 4 sale CVKDUnusual
    Jun 15, 2026 +5 days

    Sold 18,124 shares at $3.88 ($70k)

    Pham Quang X, Chairman, CEO and Interim CFO

    No 10b5-1 planSold 12% of holdings ($586k position)132,715 shares left5x usual sizeFiling

  5. 5 Form 4 sale CVKDRoutine
    Jun 17, 2026 +2 days

    Sold 4,126 shares at $3.18 ($13k)

    Pham Quang X, Chairman, CEO and Interim CFO

    10b5-1 planSold 3.1% of holdings ($422k position)128,589 shares left1x usual sizeFiling

  6. 6 Form 4 sale CVKDRoutine
    Jun 23, 2026 +6 days

    Sold 11,444 shares at $3.48 ($40k)

    Pham Quang X, Chairman, CEO and Interim CFO

    10b5-1 planSold 8.9% of holdings ($448k position)117,145 shares left2.8x usual sizeFiling

  7. 7 Form 4 sale CVKDRoutine
    Jun 26, 2026 +3 days

    Sold 11,156 shares at $3.04 ($34k)

    Pham Quang X, Chairman, CEO and Interim CFO

    10b5-1 planSold 9.5% of holdings ($356k position)105,989 shares left2.4x usual sizeFiling

  8. 8 Form 4 sale CVKDRoutine
    Jun 29, 2026 +3 days

    Sold 7,400 shares at $3.03 ($22k)

    Pham Quang X, Chairman and CEO

    10b5-1 planSold 7% of holdings ($321k position)98,589 shares left1.5x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (16)

Form 144 notices and Form 4 sales by Pham Quang X
Source
Jun 29, 2026Jul 1, 2026CVKDChairman and CEOForm 4 sale7,400$22k7.0%RoutineSEC
Jun 26, 2026Jun 26, 2026CVKDChairman, CEO and Interim CFOForm 4 sale11,156$34k9.5%RoutineSEC
Jun 23, 2026Jun 24, 2026CVKDChairman, CEO and Interim CFOForm 4 sale11,444$40k8.9%RoutineSEC
Jun 17, 2026Jun 18, 2026CVKDChairman, CEO and Interim CFOForm 4 sale4,126$13k3.1%RoutineSEC
Jun 15, 2026Jun 15, 2026CVKDChairman, CEO and Interim CFOForm 4 sale18,124$70k12.0%UnusualSEC
Jun 10, 2026Jun 10, 2026CVKDChairman, CEO and Interim CFOForm 4 sale22,385$93k12.9%UnusualSEC
Jun 5, 2026Jun 5, 2026CVKDCEO and ChairmanForm 4 sale8,285$36k4.6%UnusualSEC
Jun 2, 2026Jun 2, 2026CVKDCEO and ChairmanForm 4 sale652$3k0.4%RoutineSEC
May 28, 2026May 29, 2026CVKDCEO and ChairmanForm 4 sale12,763$69k6.5%UnusualSEC
May 22, 2026May 26, 2026CVKDCEO and ChairmanForm 4 sale1,165$7k0.6%RoutineSEC
Oct 27, 2025Oct 28, 2025CVKDCEO and ChairmanForm 4 sale2,444$34k1.2%RoutineSEC
Oct 13, 2025Oct 14, 2025CVKDCEO and ChairmanForm 4 sale3,600$51k1.8%RoutineSEC
Oct 2, 2025Oct 3, 2025CVKDCEO and ChairmanForm 4 sale500$7k0.2%RoutineSEC
Oct 1, 2025Oct 1, 2025CVKDCEO and ChairmanForm 4 sale1,300$18k0.6%RoutineSEC
Sep 25, 2025Sep 26, 2025CVKDCEO and ChairmanForm 4 sale9,371$132k4.4%RoutineSEC
Aug 28, 2025Aug 29, 2025CVKDCEO and ChairmanForm 4 sale5,029$70k2.3%RoutineSEC